Novium

Novium of CA is a bio-pharmaceutical cannabis firm focused on cutting edge cannabis science and research. The company is seeking $500,000 to fuel sales growth and scaling, hire sales reps, expand promotions, marketing and additional inventory for its California launch.

Novium always puts patients first and has 40-plus years of R&D experience with an IP catalog of more than 70 active, novel cannabis therapy formulations targeting over 20 disease states and conditions. In addition, Novium’s parent company, GCC Endeavors, is preparing to launch a recreational brand (Arbor) in both California and Oregon. Segmentation of the company’s distinct brands allows differentiation of medical-facing brands from recreational brands.

The company’s leadership team has extensive experience at working with government regulators, developing new product lines, managing national sales forces, corporate tax management, banking, operations and land development.

Revenue will be generated initially via sales at wholesale/distribution and the dispensary/pharmacy retail level. Eventually, Novium will generate additional revenue through selling flower, oil and trim through wholesale distribution networks, as well as licensing agreements. Novium will launch three to four lines of vape cartridges and follow with a proprietary, revolutionary pen to address growing demand from patients for vaporized consumption. Then the company will follow with its line of extended release tablets and topicals targeting certain high-density disease states/symptom pathologies.

For more information, visit www.noviumrx.com.